Recently, Fujita (2017) showed the antitumor effect of TGZ in pancreatic cancer cells in vitro and in vivo, suggesting that TGZ treatment is a potential approach for pancreatic cancer [58]. The gene discussed is TGM7; the disease is familial pancreatic carcinoma.